'Phase ii trial' diaporamas de présentation

CAELYX CLINICAL TRIALS Metastatic Breast Cancer (MBC)

CAELYX CLINICAL TRIALS Metastatic Breast Cancer (MBC). Clinical Benefits of CAELYX in Breast Cancer. Anthracycline with cardiac sparing effect Significantly reduced risk of cardiotoxicity Preserves cardiac function for patients who can benefit from long-term anthracycline therapy

1.16k views • 56 slides

Work in Progress

Work in Progress. Scott M. Schuetze, M.D., Ph.D. Associate Professor University of Michigan Ann Arbor. Disclosure. I submitted an abstract, and my abstract was selected for poster presentation. I will not be discussing my poster. Value of abstract presentation.

386 views • 29 slides

Blood Substitutes for Hemorrhagic Shock

Blood Substitutes for Hemorrhagic Shock. Matthew Zuckerman, M4 Medical Therapeutics University of Michigan Medical School. Why Important. Moore: Shock, Volume 24(3).September 2005.197-205. Where Important. Moore: Shock, Volume 24(3).September 2005.197-205. History of Blood Substitutes.

281 views • 24 slides

Aggiornamenti scientifici di NAB-paclitaxel nel MBC in terapia di combinazione

294 views • 19 slides

ACOSOG Sarcoma Committee

440 views • 13 slides

ACOSOG Sarcoma Committee

256 views • 13 slides

Phase II Trial of Ipilimumab Monotherapy in Melanoma Patients with Brain Metastases

Phase II Trial of Ipilimumab Monotherapy in Melanoma Patients with Brain Metastases. Lawrence DP et al. Proc ASCO 2010;Abstract 8523. Introduction.

237 views • 12 slides

Authors: Dr. Sunil Verma Date posted: June 22 nd , 2009

151 views • 6 slides